3-iodobenzylguanidine has been researched along with metoclopramide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asaka, S; Ito, Y; Masunaga, T; Oiwake, H; Shinozaki, K; Tagawa, S; Takayama, Y; Takeda, R; Yoshimura, A | 1 |
Tsuji, Y; Yokoyama, H | 1 |
1 review(s) available for 3-iodobenzylguanidine and metoclopramide
Article | Year |
---|---|
Pheochromocytoma in a long-term hemodialysis patient, discovered as an adrenal incidentaloma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Epinephrine; Humans; Iodine Radioisotopes; Iodobenzenes; Kidney Failure, Chronic; Male; Metoclopramide; Middle Aged; Norepinephrine; Pheochromocytoma; Renal Dialysis; Tomography, X-Ray Computed | 1997 |
1 trial(s) available for 3-iodobenzylguanidine and metoclopramide
Article | Year |
---|---|
[Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Topics: 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Adult; Biomarkers; Catecholamines; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Metoclopramide; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 1999 |